studies recommending that at least 50 laparoscopic colorectal surgery cases are required to gain proficiency.
11,12
These variations in the guidelines and recommendations suggest that there is still no consensus among medical and surgical communities in the United States about the adoption of laparoscopy in the management of rectal cancer. We will review the current literature and data pertaining to laparoscopic resection of rectal cancer and identify that there is still divergent evidence pertaining to the short-term cancer outcomes and limited long-term survival data. Some studies have shown that laparoscopic proctectomy has been shown to have similar results to open proctectomy with respect to various oncologic parameters, including completeness of the total mesorectal excision (TME), involvement of the circumferential resection margin (CRM), and the number of harvested lymph nodes (HLN). However, when comparing laparoscopic to open technique, there is still not enough evidence to prove similar long-term outcomes, and indeed new data have emerged questioning short-term outcomes in laparoscopic rectal cancer surgery. This remains the most important barrier to the adoption of laparoscopic proctectomy as the "gold standard" in the management of rectal cancer.
Outcomes
As mentioned earlier, laparoscopy for colon resection compared with open resections is now believed to be safe and beneficial with regard to LOS, recovery time, cosmesis, and equivalent long-term oncologic outcomes.
2-6,13,14 In contrast, the evidence behind the use of laparoscopy for rectal cancer remains controversial and inconclusive. This is partly due to the technical difficulty and complexity of this technique. It is also due to the challenges of measuring short-and long-term outcomes, as evidenced by some studies showing a significant variability in the outcomes of hospitals and surgeons across the United States.
15,16

Short-Term Outcome and Oncologic Parameters
Local recurrence is related to several oncologic parameters that can be objectively measured. These include completeness of the TME, involvement of the CRM, and number of HLN. 17 In fact, in three large randomized controlled trials (COLOR II, CLASICC, and COREAN) and in a large-scale multicenter prospective review by Lujan et al, there were no statistical differences in those parameters when laparoscopic and open approaches were compared. 
Sexual and Urinary Complications, Quality of Life
Sexual and urinary dysfunction is an established risk after any type of pelvic surgery. This applies specifically to proctectomy for rectal cancer with TME, due to the proximity of the autonomic nerves innervating the urogenital system to the surgical field. Jayne et al reported the outcomes of 247 patients from the CLASICC trial who underwent laparoscopic or open rectal resection. 28 Bladder dysfunction was similar in both groups. There was a trend toward worse sexual dysfunction in the laparoscopic group, but the difference was not statistically significant. 
The limitation of these studies and many others was that they were single-institution, retrospective studies. Therefore, no conclusive evidence on the long-term effectiveness of laparoscopic proctectomy could be made. However, two large, multicenter randomized controlled trials reporting on long-term outcomes have been published, including the previously cited CLASICC trial and the COREAN trial. The results from the major multicenter randomized controlled trials for laparoscopy in rectal cancer are shown in ►Table 1.
In two separate publications, Jayne at al reported on the long-term outcomes of the patients who were originally included in the CLASSIC trial.
14, 19 The higher positivity of the CRM that was reported after laparoscopic anterior resection did not translate into an increased incidence of local The surgical community awaits more long-term follow-up data regarding outcomes from other similar trials to more fully understand the application of laparoscopy for rectal cancer. Although the results of these previous studies showed effectiveness of laparoscopic proctectomies and similar survival rates compared with open surgery, more data will need to be published before firm conclusions can be drawn. To that matter, the true long-term outcomes from the ACOSOG Z6051 and the ALaCaRT trials should become available within the next few years to shed more light on that subject.
Different Techniques, Approaches, and Variations
Many variations to the standard totally laparoscopic surgery have been described and are routinely performed in many centers in the United States. Some of these techniques have been shown to have similar outcomes, with some advantages related to each technique. Below is a brief description of these variations, with the available evidence supporting their use.
Hand-assisted laparoscopic surgery (HALS) is a hybrid operation that was introduced as an alternative to totally laparoscopic surgery in the mid-1990s. It became increasingly popular in the last decade with the introduction of new vessel-sealing devices like the Harmonic Scalpel (Harmonic Ethicon EndoSurg, NJ) and Ligasure (Ligasure Covidien Surg, MN) as well as various laparoscopic stapling instruments. The HALS technique allows the surgeon to introduce his/her hand through a special hand port into the abdominal cavity without losing pneumoperitoneum. It grants tactile feedback to the surgeon and allows the surgeon's hand to assist in retraction, dissection, and organ retrieval. Tjandra et al reported in a prospective study the outcomes of 63 patients undergoing ultralow anterior resection using either a laparoscopic-assisted technique or HALS. 36 Both techniques were shown to have similar blood loss, hospital LOS, and oncologic parameters including involvement of the CRM and the number of HLN. The standard laparoscopic approach, however, had significantly longer operative time. Other studies showed similar results regarding favorable outcomes with HALS in colorectal procedures, with low conversion rates and morbidity/mortality rates comparable to laparoscopic and open techniques. 37, 38 A review article published in December 2010 looking at available literature regarding HALS concluded that long-term outcomes and complications, as well as cost were similar to the totally laparoscopic technique. 39 The challenge of this technique, however, is the number of cases to achieve technical proficiency, which was found to be 105 cases in a retrospective study published by Pendlimari et al, implying that the learning curve would likely extend beyond fellowship training for many colorectal surgeons.
40
Robotic-assisted surgery (RAS) is the main technical innovation to colorectal surgery since laparoscopy was introduced. The robotic Da Vinci system was developed in the early 2000s, with the purpose of improving visibility with 3D imaging, increasing the range of motion with higher degrees of articulation and rotation, and reducing the need for a skilled surgical assistant. In theory, surgical dissection in narrow spaces such as the pelvis would be easier and safer. Many studies, however, failed to show that advantage, and there have been conflicting data published in the last few years. Baek at al analyzed 64 consecutive rectal cancer patients with stage I-III rectal cancer who underwent robotic-assisted TME. 41 They were able to demonstrate local recurrence rate, disease-free survival, and overall survival similar to those of laparoscopic and open surgery. A review of the literature by Trastulli et al came to the conclusion that robotic surgery for rectal cancer had lower conversion rate, with similar operative time, oncologic outcome, and postoperative morbidity when compared with laparoscopic proctectomy. 42 The limitation of that review is that the eight studies included were non-andomized. A more recent systematic review and meta-analysis by Lorenzon et al published in September 2015 included 22 studies, totaling 1,652 laparoscopic and 1,120 robotic-assisted colorectal resections. 43 The result of that analysis was that laparoscopic procedures were shorter in time, with less blood loss, while robotic assisted procedures had less perioperative complications. Those differences, however, were not evident when the analysis was focused exclusively on the available randomized trials. Furthermore, Fung and Aly concluded in their review that both operative time and cost were significantly higher with RAS, questioning whether the surgical community should embark on a new learning curve for this technique.
44
Single incision laparoscopic surgery (SILS) is a relatively new technique where a single umbilical incision is used to place one port, which accommodates articulating instruments that allow "pseudotriangulation." This technique has been widely described for appendectomies and cholecystectomies over the last few years, but only a few reports have been published about this technique being used for rectal surgery. Law et al were the first to report their series of eight cancer patients undergoing colon and rectal resections, suggesting this technique is safe and feasible. 45 The same results were found in other small case reports and series. 
Challenges and Barriers to Implementation
A few barriers have delayed the adoption of laparoscopic proctectomy as standard of care for the management of rectal cancer. Technical difficulty, steep learning curves, and questionable cost-effectiveness of laparoscopy are some of the challenges. Operating in the pelvis can be technically difficult due to the osseous structures narrowing that anatomic space. For an adequate oncologic resection, a TME must be achieved while avoiding injuries to surrounding structures including pelvic nerves and ureters. Those difficulties are magnified when we add the challenges of laparoscopy. These include limitations of instrument and endoscopic stapler angulations as well as the inability to palpate and feel the extent of the tumor. These limitations inevitably raise the question of adequate surgeon training and learning curves. SAGES suggests that proficiency in laparoscopic rectal surgery requires 50 cases. 10 On the other hand, Kim et al studied the performance of 317 consecutive laparoscopic proctectomies. 50 Using a risk-adjusted cumulative sum analysis, they demonstrated a learning curve of 110 cases to achieve short-term outcomes and a local recurrence rate similar to an experienced surgeon. Furthermore, Lujan et al demonstrated that it was possible to complete the learning process without compromising patient safety or oncologic outcomes. 51 Interestingly, one study found that learning curves for robotic proctectomies were steeper than those of laparoscopic proctectomies after 41 cases, with acceptable perioperative outcomes. 52 We therefore think that it is crucial for a surgeon performing laparoscopy for rectal cancer to have undergone adequate training during residency and fellowship before independently operating on these patients. Another issue that might impede the adoption of minimally invasive proctectomies is the cost of such procedures. Despite popular beliefs that laparoscopy costs more than open surgery because of instrument requirements and longer operative time, data actually suggest there is no difference in cost or cost savings when comparing these different techniques. Ramji at al performed a 6-year retrospective review of rectal cancer operations in a tertiary care center in Toronto, Canada.
53 They found no significant difference in cost between laparoscopic and open operations. Robotic cases, however, added around $6,000 to the overall cost of the hospitalization. Furthermore, Keller et al performed a review of a prospective database for laparoscopic rectal cancer operations at a large tertiary referral center in the United States. 54 They found that laparoscopic rectal cancer resection reduces length of stay, operating time, and resource utilization, and thus found a significant reduction in overall hospital cost when compared with open procedures ($17,200 vs. $21,800). The limitations of that study are that it was a retrospective review performed at a single institution. On the other hand, Jensen at al created a model investigating the cost-effectiveness of laparoscopic surgery for colon and rectal cancer using data from previously published large randomized trials. 55 They found that the laparoscopic approach was significantly less costly than the open approach with savings of $4,283, and no difference in quality of life.
In light of the available and sometimes conflicting literature on the topic, we think that the most important barrier to widespread adoption of laparoscopic proctectomy for rectal cancer remains the paucity of convincing evidence that it has similar long-term outcomes when compared with open surgery, especially in specific groups of patients. More randomized trials addressing the contradictory results found in previously published studies should be considered before laparoscopy becomes more widely accepted as the "standard of care" in the treatment of patients with rectal cancer.
Conclusion
In conclusion, the current evidence suggests that the laparoscopic approach is equivalent to an open approach for proctectomies in the management of rectal cancer, with similar short-term perioperative outcomes primarily in morbidity and mortality. The limited current evidence suggests longterm outcomes and survival are similar in both groups, especially in early stage tumors. There is, however, not enough convincing evidence but rather conflicting data regarding the use of laparoscopy in locally advanced and distal rectal cancers with respect to short-term cancer outcomes. Further studies and trials are required before more conclusive arguments can be made to support the universal use of laparoscopy in the surgical management of rectal cancer.
